Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST004205)

(Analysis AN006992)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10
N-Oleoylethanolamine	ME1136253	NA	NA	NA	3.21	0.24	NA	NA	0.26	3.21	0.28
DG(18:0_22:6)	ME1136212	0.20	0.26	1.59	0.72	0.95	1.00	1.46	0.96	1.58	0.88
TG(18:1_34:3)	ME1136303	1.31	1.47	0.80	0.32	0.22	0.98	0.42	0.21	2.42	2.16
TG(18:1_34:2)	ME1136302	1.41	1.09	0.70	0.41	0.22	0.99	0.70	0.23	2.61	1.63
TG(20:4_36:2)	ME1136308	1.75	0.95	0.76	0.56	0.21	0.90	0.85	0.30	2.30	1.32
TG(20:4_34:3)	ME1136306	1.40	2.60	1.48	0.40	0.46	0.96	0.33	0.46	1.17	2.05
PE(40:7)	ME1136285	1.30	1.86	1.09	0.87	0.65	0.99	0.50	0.45	1.34	1.62
TG(20:4_36:3)	ME1136309	1.72	1.51	1.21	0.60	0.34	0.94	0.67	0.52	1.42	1.49
TG(20:4_32:1)	ME1136304	1.59	1.74	1.16	0.44	0.30	0.92	0.54	0.35	1.71	1.84
TG(20:4_34:2)	ME1136305	1.55	1.54	1.08	0.42	0.29	0.91	0.50	0.36	1.85	1.92
LPC(18:1)	ME1136234	1.26	0.81	0.82	1.60	0.77	0.94	1.35	0.78	1.03	0.47
PC(O-18:0/2:0)	ME1136271	1.28	0.63	0.79	1.72	0.79	0.91	1.56	0.79	0.87	0.34
LPC(16:0)	ME1136230	1.27	0.72	0.81	1.83	0.79	0.93	1.58	0.80	0.71	0.29
LPC(18:0)	ME1136232	1.29	0.65	0.75	1.88	0.81	0.91	1.52	0.79	0.76	0.30
DG(18:0_20:4)	ME1136211	1.70	0.40	0.26	3.01	0.15	0.82	1.52	0.13	1.21	0.17
DG(18:1_20:4)	ME1136214	1.57	0.84	0.61	2.06	0.23	0.90	1.19	0.25	1.58	0.56
DG(16:0_20:4)	ME1136209	1.55	0.94	0.70	2.31	0.34	0.88	1.25	0.41	1.09	0.40
DG(18:0_18:1)	ME1136210	1.51	0.58	0.41	2.45	0.38	0.89	1.36	0.39	1.12	0.44
Cholesteryl hexoside	ME1136205	1.50	0.57	0.35	1.12	0.30	0.77	2.50	0.37	1.73	0.30
LPC(24:0)	ME1136237	2.06	0.54	0.32	1.33	0.26	0.79	2.03	0.25	1.79	0.11
LPC(24:1)	ME1136238	2.02	0.38	0.25	1.28	0.24	0.76	2.04	0.21	2.08	0.09
LacCer(d18:1/18:0)	ME1136243	1.46	0.40	0.27	1.42	0.34	0.83	1.90	0.31	1.96	0.48
HexCer(d18:1/18:0)	ME1136225	1.78	0.35	0.20	1.76	0.21	0.79	1.78	0.21	2.03	0.19
Cer(d18:1/18:0)	ME1136200	1.77	0.67	0.43	1.58	0.31	0.80	1.72	0.34	1.78	0.21
HexCer(d18:1/24:1)	ME1136228	1.76	0.50	0.30	1.65	0.29	0.93	1.76	0.27	1.79	0.21
LPC(26:0)	ME1136239	1.57	0.48	0.48	1.09	0.48	0.48	1.33	0.48	1.57	0.48
LPC(26:1)	ME1136240	1.61	0.38	0.38	1.14	0.38	0.66	1.51	0.38	1.32	0.38
PC(36:1)	ME1136262	1.56	0.93	0.63	1.43	0.44	1.03	1.39	0.46	1.46	0.53
Cer(d18:1/24:1)	ME1136202	1.71	0.73	0.55	1.49	0.36	0.90	1.70	0.34	1.57	0.34
HexCer(d18:1/22:0)	ME1136226	1.65	0.93	0.54	1.43	0.51	0.88	1.67	0.57	1.39	0.27
HexCer(d18:1/24:0)	ME1136227	1.73	0.88	0.51	1.42	0.46	0.89	1.67	0.50	1.53	0.22
TG(18:0_36:2)	ME1136301	1.58	0.79	0.52	0.68	0.21	0.93	1.32	0.35	2.61	0.72
TG(20:4_36:0)	ME1136307	1.99	0.94	0.69	0.75	0.29	0.90	1.30	0.42	2.08	0.52
DG(18:1/18:1)	ME1136213	1.45	0.83	0.59	1.55	0.26	0.94	1.05	0.25	2.01	0.85
PE(36:2)	ME1136277	1.47	1.09	0.60	1.48	0.37	0.91	0.95	0.28	1.61	1.21
LacCer(d18:1/16:0)	ME1136241	0.81	0.48	0.53	0.94	0.63	0.85	1.33	0.65	1.95	1.32
LacCer(d18:1/24:1)	ME1136245	1.32	0.65	0.41	1.06	0.45	0.89	1.56	0.40	2.02	0.82
Palmitoylethanolamine	ME1136286	1.38	0.98	0.63	NA	0.76	1.73	1.67	0.65	1.27	0.83
PC(16:0/5:0(CHO))	ME1136256	0.87	1.28	1.28	0.96	1.37	1.19	0.91	1.42	0.46	0.55
PC(O-16:0/2:0)	ME1136270	1.01	0.78	0.99	0.94	0.82	1.08	1.45	1.07	1.03	0.67
PC(O-16:0/0:0)	ME1136269	0.95	0.95	0.95	1.42	0.95	0.95	0.95	0.95	0.95	0.95
PC(16:0/9:0(COOH))	ME1136258	0.99	0.88	1.02	1.10	0.88	0.99	0.88	1.10	1.21	0.88
MG(16:0)	ME1136247	0.92	0.82	0.90	1.09	0.93	1.04	1.19	0.90	1.08	0.98
MG(18:0)	ME1136249	0.94	0.88	0.84	1.12	0.93	0.98	1.16	0.97	1.05	1.00
MG(18:1)	ME1136251	0.95	0.88	0.80	1.12	0.92	1.02	1.15	0.92	1.12	1.00
PC(36:2)	ME1136263	1.33	1.26	0.85	0.96	0.58	1.01	0.91	0.54	1.53	1.19
PE(34:1)	ME1136275	1.45	1.54	0.90	1.22	0.52	0.96	0.83	0.42	1.37	1.18
SM(d18:1/18:0)	ME1136289	1.37	1.56	0.97	1.06	0.67	0.99	0.90	0.56	1.35	0.97
SM(d18:1/24:1)	ME1136291	1.36	1.62	1.08	0.93	0.70	1.05	0.82	0.55	1.29	1.07
LPC(22:6)	ME1136236	1.39	1.29	0.93	0.99	0.72	1.04	1.02	0.75	1.31	0.75
HexCer(d18:1/16:0)	ME1136224	1.22	1.29	0.84	0.97	0.77	0.96	1.08	0.74	1.19	1.11
PC(34:1)	ME1136261	1.21	1.19	0.97	1.06	0.77	1.01	1.02	0.76	1.13	1.02
PC(16:0/9:0(CHO))	ME1136257	1.08	1.01	1.10	0.88	0.72	1.01	0.91	0.83	1.24	1.25
SM(d18:1/16:0)	ME1136288	1.17	1.40	1.04	0.85	0.79	1.01	0.80	0.72	1.24	1.28
PE(36:1)	ME1136276	1.52	1.31	0.80	1.23	0.53	0.93	1.05	0.51	1.41	0.88
PE(38:5)	ME1136280	1.52	1.47	0.81	1.41	0.60	0.94	0.98	0.48	1.20	0.89
Cholesterol	ME1136203	1.54	1.29	0.76	1.60	0.54	0.91	1.17	0.47	1.25	0.63
DG(16:0_18:1)	ME1136208	1.48	1.14	0.72	1.55	0.42	0.99	1.08	0.44	1.43	0.78
Cer(d18:1/16:0)	ME1136199	1.41	1.20	0.94	1.09	0.61	0.92	1.47	0.65	1.11	0.72
LacCer(d18:1/24:0)	ME1136244	1.42	1.06	0.60	1.10	0.62	0.90	1.62	0.59	1.35	0.70
GB3(d18:1/16:0)	ME1136215	1.82	2.17	1.30	0.83	0.68	0.94	0.95	0.84	0.76	0.67
PE(38:6)	ME1136281	1.46	2.21	1.21	1.25	0.86	1.00	0.70	0.57	0.85	0.85
Coenzyme Q10	ME1136206	1.50	2.05	1.11	0.95	0.91	0.95	0.87	0.87	0.91	0.71
PE(40:4)	ME1136282	1.45	2.09	1.17	0.93	0.72	1.00	0.77	0.77	1.01	0.95
PE(40:6)	ME1136284	1.47	1.93	1.12	1.10	0.72	1.01	0.75	0.56	1.07	1.00
PC(38:6)	ME1136266	1.63	1.99	1.12	1.07	0.71	0.99	0.86	0.55	1.04	0.81
SM(d18:1/24:0)	ME1136290	1.61	1.99	1.15	0.89	0.64	1.07	0.86	0.56	1.20	0.83
LPC(16:1)	ME1136231	1.18	1.58	1.13	1.00	0.87	1.04	0.93	0.83	1.00	0.91
PE(38:4)	ME1136279	1.33	1.69	1.05	1.05	0.85	1.02	0.94	0.76	0.96	0.88
PC(40:6)	ME1136268	1.57	1.57	1.08	1.19	0.76	0.98	0.95	0.60	1.05	0.69
PE(36:4)	ME1136278	1.52	1.83	0.99	1.36	0.82	0.97	0.92	0.64	0.88	0.70
PC(40:5)	ME1136267	1.45	1.55	1.03	1.18	0.88	1.02	1.10	0.88	0.74	0.60
PC(36:4)	ME1136264	1.16	1.28	1.02	1.13	1.04	1.04	1.12	1.00	0.77	0.65
PC(38:4)	ME1136265	1.25	1.47	1.04	1.19	1.08	1.07	1.19	1.01	0.61	0.45
GB3(d18:1/18:0)	ME1136217	1.56	1.44	1.15	0.80	0.82	0.98	1.28	0.98	0.84	0.50
GB3(d18:1/24:1)	ME1136219	1.31	1.43	0.93	0.85	0.73	0.99	1.45	1.11	0.87	0.65
LPC(20:4)	ME1136235	1.15	1.48	0.99	0.95	0.93	1.11	1.33	1.20	0.75	0.47
Cer(d18:1/24:0)	ME1136201	1.76	1.77	0.96	1.12	0.53	0.88	1.55	0.56	1.00	0.44
GB3(d18:1/24:0)	ME1136218	1.57	1.83	0.69	0.94	0.67	1.13	1.73	1.05	0.55	0.38
TG(22:6_36:2)	ME1136310	1.71	0.60	0.42	0.42	0.10	0.82	0.60	0.11	3.74	1.03
TG(22:6_38:1)	ME1136311	1.64	0.16	0.16	0.66	0.16	0.78	1.17	0.16	3.28	0.35
TG(22:6_38:2)	ME1136312	1.78	0.32	0.27	0.58	0.08	0.82	0.90	0.08	3.60	0.64
CE(20:4)	ME1136191	1.61	0.12	0.16	0.82	0.07	0.78	3.54	0.09	1.83	0.10
CE(20:5)	ME1136192	2.08	0.06	0.06	0.84	0.02	0.61	3.83	0.04	1.48	0.04
Sphingosine	ME1136295	1.96	0.15	0.13	1.07	0.08	0.76	2.17	0.11	2.61	0.10
Sphinganine 1-phosphate	ME1136294	2.20	0.14	0.13	0.69	0.08	0.70	1.84	0.06	3.16	0.13
Sphingosine 1-phosphate	ME1136296	2.27	0.20	0.12	0.78	0.11	0.66	2.00	0.12	2.79	0.12
CE(22:6)	ME1136193	1.82	0.05	0.05	0.56	0.02	0.68	3.16	0.02	2.66	0.04
CE(18:1)	ME1136189	1.07	0.15	0.17	0.46	0.14	0.81	2.78	0.14	3.28	0.15
CE(16:1)	ME1136187	1.11	0.25	0.33	0.60	0.20	1.00	2.51	0.20	2.85	0.21
CE(18:2)	ME1136190	1.24	0.30	0.42	0.65	0.21	0.92	2.58	0.22	2.53	0.26

Factors:

F1	Genotype:GPR34-KO \| Treatment:Myelin \| Sample source:iMicroglia
F2	Genotype:GPR34 KO \| Treatment:PBS \| Sample source:iMicroglia
F3	Genotype:GPR34-KO \| Treatment:PBS \| Sample source:iMicroglia
F4	Genotype:GPR34/TREM2-KO \| Treatment:Myelin \| Sample source:iMicroglia
F5	Genotype:GPR34/TREM2-KO \| Treatment:PBS \| Sample source:iMicroglia
F6	Genotype:NA \| Treatment:NA \| Sample source:iMicroglia
F7	Genotype:TREM2-KO \| Treatment:Myelin \| Sample source:iMicroglia
F8	Genotype:TREM2-KO \| Treatment:PBS \| Sample source:iMicroglia
F9	Genotype:WT \| Treatment:Myelin \| Sample source:iMicroglia
F10	Genotype:WT \| Treatment:PBS \| Sample source:iMicroglia

Data matrix